Boehringer Ingelheim is concentrating on expanding its pipeline beyond Jardiance and other key products.
Tag Archive for: Spevigo
The FDA has approved Boehringer Ingelheim’s Spevigo (spesolimab) for generalized pustular psoriasis (GPP) flares in adults, making it the first drug approved for this indication.
